These findings are consistent with our own previous results [27, 33, 34] and with other previous studies reporting the role of an immune-inflammatory activation involving inflammatory cytokines [20, 21] and CD4+CD28 null T cell subsets [22–25] in the acute phase of ischemic stroke. The gene discussed is CD28; the disease is ischemic stroke.